La diabetes mellitus en España: mortalidad, prevalencia, incidencia, costes económicos y desigualdades

Ruíz-Ramos, Miguel; Escolar-Pujolar, Antonio; Mayoral-Sánchez, Eduardo; Laureano, Florentino Corral-San; Fernández-Fernández, I

doi:10.1157/13086022

Cited by 148 publications

(62 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Second, the component studies did not register the specific type of diabetes (1 or 2). However, the prevalence of type 1 diabetes in our country ranged between 0.08 and 0.2%, whereas type 2 diabetes affects between 4.8 and 18.7% (40). Indeed, the Emerging Risk Factors Collaboration authors (5) did not distinguish between the types of diabetes in their analysis.…”

Section: Characteristics and Limitationsmentioning

confidence: 74%

Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis

et al. 2016

View full text Add to dashboard Cite

OBJECTIVEDiabetes is a common cause of shortened life expectancy. We aimed to assess the association between diabetes and cause-specific death. RESEARCH DESIGN AND METHODSWe used the pooled analysis of individual data from 12 Spanish population cohorts with 10-year follow-up. Participants had no previous history of cardiovascular diseases and were 35-79 years old. Diabetes status was self-reported or defined as glycemia >125 mg/dL at baseline. Vital status and causes of death were ascertained by medical records review and linkage with the official death registry. The hazard ratios and cumulative mortality function were assessed with two approaches, with and without competing risks: proportional subdistribution hazard (PSH) and cause-specific hazard (CSH), respectively. Multivariate analyses were fitted for cardiovascular, cancer, and noncardiovascular noncancer deaths. RESULTSWe included 55,292 individuals (15.6% with diabetes and overall mortality of 9.1%). The adjusted hazard ratios showed that diabetes increased mortality risk: 1) cardiovascular death, CSH = 2.03 (95% CI 1.63-2.52) and PSH = 1.99 (1.60-2.49) in men; and CSH = 2.28 (1.75-2.97) and PSH = 2.23 (1.70-2.91) in women; 2) cancer death, CSH = 1.37 (1.13-1.67) and PSH = 1.35 (1.10-1.65) in men; and CSH = 1.68 (1.29-2.20) and PSH = 1.66 (1.25-2.19) in women; and 3) noncardiovascular noncancer death, CSH = 1.53 (1.23-1.91) and PSH = 1.50 (1.20-1.89) in men; and CSH = 1.89 (1.43-2.48) and PSH = 1.84 (1.39-2.45) in women. In all instances, the cumulative mortality function was significantly higher in individuals with diabetes. CONCLUSIONSDiabetes is associated with premature death from cardiovascular disease, cancer, and noncardiovascular noncancer causes. The use of CSH and PSH provides a comprehensive view of mortality dynamics in a population with diabetes.Diabetes constitutes a worldwide public health problem (1) that affected 382 million people (8.3% of the world's population) in 2013 (2). Recent projections suggest that this prevalence is likely to increase in the next 20 years, affecting 592 million people (10.1%) in 2035. In Spain, diabetes affects 13.8% of individuals older than 18 years and is more prevalent in men than in women (3,4).The average life expectancy of a 50-year-old individual with diabetes is 6 years shorter than it would be without the disease (5). Diabetes not only doubles or

show abstract

Section: Characteristics and Limitationsmentioning

confidence: 74%

Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Diabetes trends in Europe are alarming, given the notable increase in prevalence in most countries (Passa 2002). Spain is not an exception and diabetes has become an important public health problem because of its growing magnitude and its impact on CVD (Ruiz-Ramos et al 2006). A combination of several factors, such as changes in the diagnostic criteria for diabetes, population aging, and lower mortality among persons with diabetes, has led to an increase in disease prevalence (Valdés et al 2007).…”

Section: Trends In Diseasesmentioning

confidence: 99%

Are we living longer but less healthy? Trends in mortality and morbidity in Catalonia (Spain), 1994–2011

Solé-Auró

Alcañiz

2014

Eur J Ageing

View full text Add to dashboard Cite

Evidence on trends in prevalence of disease and disability can clarify whether countries are experiencing a compression or expansion of morbidity. An expansion of morbidity, as indicated by disease, has appeared in Europe and other developed regions. It is likely that better treatment, preventive measures, and increases in education levels have contributed to the declines in mortality and increments in life expectancy. This paper examines whether there has been an expansion of morbidity in Catalonia (Spain). It uses trends in mortality and morbidity and links these with survival to provide estimates of life expectancy with and without diseases and mobility limitations. We use a repeated cross-sectional health survey carried out in 1994 and 2011 for measures of morbidity, and information from the Spanish National Statistics Institute for mortality. Our findings show that at age 65 the percentage of life with disease increased from 52 to 70 % for men, and from 56 to 72 % for women; the expectation of life with mobility limitations increased from 24 to 30 % for men and from 40 to 47 % for women between 1994 and 2011. These changes were attributable to increases in the prevalence of diseases and moderate mobility limitation. Overall, we find an expansion of morbidity along the period. Increasing survival among people with diseases can lead to a higher prevalence of diseases in the older population. Higher prevalence of health problems can lead to greater pressure on the health care system and a growing burden of disease for individuals.

show abstract

“…mproving health-related quality of life among individuals with diabetes is a public health goal (1). The U.S. government-published Healthy People 2010 includes self-rated health as one of three surveillance tools that can be used to measure health-related quality of life (2).…”

mentioning

confidence: 99%

Ten-Year Trends in Self-Rated Health Among Spanish Adults With Diabetes, 1993–2003

Jiménez‐García

Trujillo²,

Hernández‐Barrera³

et al. 2008

Diabetes Care

View full text Add to dashboard Cite

OBJECTIVE -Improving health-related quality of life among individuals with diabetes is a public health goal. This study sought to assess trends in self-rated "fair" and "poor" health among Spanish adults with diabetes and to identify factors associated with fair and poor health using data from all five National Health Surveys conducted from 1993 to 2003. RESULTS -The most relevant finding of this study is that, among Spanish adults with diabetes, prevalence of fair or poor heath is more than double that of individuals without diabetes and that overall prevalence did not vary during the decade 1993-2003 (71.2 to 70.5%). The variables associated with an increased risk of self-rated fair or poor health were as follows: age 54 -64 years (odds ratio [OR] 1.5) or Ն65 years (2.1), presence of comorbidity (4.3), female sex (1.2), lower educational level (1.7), obesity (1.3), and no physical activity (1.6). RESEARCH DESIGN AND METHODSCONCLUSIONS -The lack of improvement in self-rated health among Spanish adults with diabetes calls for urgent implementation of health-promotion, prevention, and diabetesmanagement strategies aimed at enhancing the quality of life of such individuals. Diabetes Care 31:90-92, 2008

show abstract

La diabetes mellitus en España: mortalidad, prevalencia, incidencia, costes económicos y desigualdades

Cited by 148 publications

References 37 publications

Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis

Risk of Cause-Specific Death in Individuals With Diabetes: A Competing Risks Analysis

Are we living longer but less healthy? Trends in mortality and morbidity in Catalonia (Spain), 1994–2011

Ten-Year Trends in Self-Rated Health Among Spanish Adults With Diabetes, 1993–2003

Contact Info

Product

Resources

About